Published on
Dec 14, 2024
Down 50% with a 6.5% yield, is this massive S&P 500 stock a screaming buy?
During the pandemic, it was one of the most well-known S&P 500 companies in the world. Famous for being the first to develop an FDA-approved Covid vaccine, Pfizer (NYSE: PFE) quickly became a household name. Today, the pharma giant’s market-cap has …
Source:
The Motley Fool
-
Neutral
